Evidence map›Paper›PMID 30400131›Full record

ReviewNutrients2018

The Immunomodulatory and Anti-Inflammatory Role of Polyphenols.

Nour Yahfoufi, Nawal Alsadi, Majed Jambi, Chantal Matar

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06950138 (Efficacy of Triticum Aestivum Over Vascular Function in Mexican Obese Patients), which is not on this map. Cited by 756 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
756citing papers in PubMed, 3 pooled it
49.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06950138 phase3completednot on this mapstarted 2023, after this paper: background citation

Efficacy of Triticum Aestivum Over Vascular Function in Mexican Obese Patients

TypeinterventionalSponsorCoordinación de Investigación en Salud, MexicoRan2023 to 2025Enrolled20ConditionsObesity, Vascular RiskArmsTriticum aestivum, calcined magnesia
3 · Its place in the literature

Who cites it

756 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,611 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Pharmaceutical biology · 2026
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

696 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nour YahfoufiCellular and Molecular Medicine Department, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H8L1, Canada. nyahf074@uottawa.ca.
Nawal AlsadiCellular and Molecular Medicine Department, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H8L1, Canada. nalsa068@uottawa.ca.
Majed JambiCellular and Molecular Medicine Department, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H8L1, Canada. mjamb055@uottawa.ca.
Chantal MatarCellular and Molecular Medicine Department, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H8L1, Canada. Chantal.matar@uottawa.ca.
University of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review offers a systematic understanding about how polyphenols target multiple inflammatory components and lead to anti-inflammatory mechanisms. It provides a clear understanding of the molecular mechanisms of action of phenolic compounds. Polyphenols regulate immunity by interfering with immune cell regulation, proinflammatory cytokines' synthesis, and gene expression. They inactivate NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) and modulate mitogen-activated protein Kinase (MAPk) and arachidonic acids pathways. Polyphenolic compounds inhibit phosphatidylinositide 3-kinases/protein kinase B (PI3K/AkT), inhibitor of kappa kinase/c-Jun amino-terminal kinases (IKK/JNK), mammalian target of rapamycin complex 1 (mTORC1) which is a protein complex that controls protein synthesis, and JAK/STAT. They can suppress toll-like receptor (TLR) and pro-inflammatory genes' expression. Their antioxidant activity and ability to inhibit enzymes involved in the production of eicosanoids contribute as well to their anti-inflammation properties. They inhibit certain enzymes involved in reactive oxygen species ROS production like xanthine oxidase and NADPH oxidase (NOX) while they upregulate other endogenous antioxidant enzymes like superoxide dismutase (SOD), catalase, and glutathione (GSH) peroxidase (Px). Furthermore, they inhibit phospholipase A2 (PLA2), cyclooxygenase (COX) and lipoxygenase (LOX) leading to a reduction in the production of prostaglandins (PGs) and leukotrienes (LTs) and inflammation antagonism. The effects of these biologically active compounds on the immune system are associated with extended health benefits for different chronic inflammatory diseases. Studies of plant extracts and compounds show that polyphenols can play a beneficial role in the prevention and the progress of chronic diseases related to inflammation such as diabetes, obesity, neurodegeneration, cancers, and cardiovascular diseases, among other conditions.

Indexed as

AnimalsAnti-Inflammatory AgentsCytokinesGene Expression RegulationHumansImmunologic FactorsPolyphenolsAnti-Inflammatory AgentsCytokinesImmunologic FactorsPolyphenolsanti-inflammationanti-tumorigenicarachidonic acidcancerchronic inflammatory conditionscyclooxygenase (COX)cytokinesextra-cellular signal regulated kinases (ERK)immune systeminflammationinhibitor of kappa kinase (IKK)lipoxygenase (LOX)macrophagesmitogen-activated protein Kinase (MAPK)molecular mechanismsnitric oxide synthase (NOS)nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)oxidative stresspolyphenolsreactive oxygen species (ROS)superoxide dismutase (SOD)Th17T helper 1 (Th1)Treg

Identifiers

PMID30400131
PMCPMC6266803
OpenAlexW2899052178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.